Table 2.

Clinical course and outcomes in patients with ESKD on chronic hemodialysis hospitalized with COVID-19

Clinical CourseValue
Hospital admission, n (%)
 General medical floor99 (87)
 Intensive care unit15 (13)
COVID-19 Treatment, n (%)
 Hydroxychloroquine87 (76)
Anticoagulation, n (%)
 None17 (15)
 Apixaban36 (32)
 Heparin57 (50)
 Warfarin4 (14)
Mechanical ventilation according to location, n (%)19 (17)
 Intensive care unit14
 General medical floor5
Vasopressors, n (%)18 (16)
Renal replacement modality, n (%)
 Intermittent hemodialysis111 (97)
 Continuous RRT2 (2)
 Slow low-efficiency hemodialysis1 (0.8)
New thrombotic events, n (%)8 (7)
In-hospital death, n (%)32 (28)
 Intensive care unit13/15 (87)
 General medical floor19/99 (19)
In-hospital death in those requiring mechanical ventilation, n (%)18/19 (95)
Terminal extubation, n (%)6/19 (32)
Causes of death, n (%)
 Cardiac arrest14 (44)
 Respiratory failure14 (44)
 Anoxic brain injury2 (6)
 Hyperkalemia2 (6)
Death with a DNR order in place17 (53)
Hospitalization status in those alive, n (%)
 Discharges73 (64)
 Still admitted at time of study9 (8)
Hospital length of stay (days), median (IQR)
 Discharged9 (6 to 12.8)
 Died in hospital8 (4 to 14)
  • Numbers reported in table are n (%). Hospital length of stay is reported as median (IQR). COVID-19, coronavirus disease 2019; DNR, do not resuscitate; IQR, interquartile range.